2.08

0.00% 0.00

After Hours: 2.10 0.02 +0.96%

Cronos Group Inc (CRON)

Overview News Price History Option Chain Financials Discussions Forecast

Cronos Group Inc stock is traded at $2.08, with a volume of 400.77K. It is up +0.00% in the last 24 hours and down -5.02% over the past month. Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Previous Close:

$2.08

Open:

$2.09

24h Volume:

400.77K

Relative Volume:

0.40

Market Cap:

$795.17M

Revenue:

$87.89M

Net Income/Loss:

$-73.96M

P/E Ratio:

-5.4737

EPS:

-0.38

Net Cash Flow:

$-46.26M

1W Performance:

+0.00%

1M Performance:

-5.02%

6M Performance:

-18.75%

1Y Performance:

+6.12%

1-Day Range:

$2.06

$2.115

1-Week Range:

$2.06

$2.20

52-Week Range:

$1.85

$3.14

Cronos Group Inc Stock (CRON) Company Profile

Name

Cronos Group Inc

Sector

Healthcare (1180)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

(416) 504-0004

Address

4491 CONCESSION RD 12, STAYNER, ON

Employee

356

Twitter

@cronosgroup

Next Earnings Date

2024-11-12

Latest SEC Filings

CRON's Discussions on Twitter

Compare CRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRON Cronos Group Inc	2.08	795.17M	87.89M	-73.96M	-46.26M	-0.1843
ZTS Zoetis Inc	175.25	79.07B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.66	43.68B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.62	43.18B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	16.78	19.01B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	13.09	15.62B	15.05B	-883.30M	1.89B	-0.74

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-28-22	Upgrade	Canaccord Genuity	Hold → Buy
May-11-22	Upgrade	CIBC	Neutral → Sector Outperform
Mar-22-22	Upgrade	Barclays	Underweight → Equal Weight
Jan-27-22	Upgrade	Jefferies	Underperform → Hold
Nov-18-21	Resumed	BofA Securities	Underperform
Apr-28-21	Resumed	BofA Securities	Underperform
Feb-22-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-24-20	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-27-20	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-14-20	Downgrade	Piper Sandler	Overweight → Neutral
Apr-02-20	Downgrade	BofA/Merrill	Buy → Neutral
Mar-31-20	Downgrade	Canaccord Genuity	Hold → Sell
Mar-04-20	Upgrade	MKM Partners	Neutral → Buy
Mar-03-20	Downgrade	Stifel	Buy → Hold
Oct-18-19	Upgrade	Stifel	Hold → Buy
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-05-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
Aug-13-19	Initiated	Piper Jaffray	Overweight
Aug-09-19	Upgrade	Canaccord Genuity	Sell → Hold
Jun-28-19	Initiated	Consumer Edge Research	Equal Weight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Upgrade	BofA/Merrill	Underperform → Buy
Apr-17-19	Initiated	BofA/Merrill	Underperform
Mar-27-19	Downgrade	Canaccord Genuity	Hold → Sell
Feb-25-19	Initiated	Jefferies	Underperform
Jan-18-19	Initiated	CIBC	Sector Outperform

View All

Cronos Group Inc Stock (CRON) Latest News

Nov 27, 2024

Cronos Group Inc. stock outperforms market despite losses on the day - MarketWatch

Nov 27, 2024

Trulieve Cannabis Corp. Announces Insider Share Purchases By Executive Leadership and Board Members - Investing News Network

Nov 22, 2024

Nov 21, 2024

Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch

Nov 21, 2024

Cronos stock jumps 11% on Q3 earnings report - MSN

Nov 21, 2024

Nov 20, 2024